Navigation Links
Coping With New FDA Mandates For Drug Sample Distribution
Date:5/14/2012

FRESH MEADOWS, N.Y., May 14, 2012 /PRNewswire/ -- Pharmaceutical manufacturers and distributors face new Food and Drug Administration (FDA) mandates requiring reporting on drug product samples distribution using XML, and submitting the report through the FDA gateway.

To help the pharmaceutical industry cope with the new federal requirements and also to understand best practices for ongoing Standard SPL filings, Data Conversion Laboratory (DCL) is offering a free, 90-minute webinar on May 17th.

The webinar is in two parts with part one covering SPL best practices to streamline the process for accuracy and savings, and part two on the new ACA 6004 draft requirements. Topics include preparing SPL submissions, Label Image Size and Legibility requirements, Establishment Registration, National Drug Code Labeler Code Requests, and Gateway Submission. To register visit: https://www3.gotomeeting.com/register/218892550.

SPL is a document markup standard used by the FDA community to facilitate the communication of drug labeling data reliably between the FDA, drug makers and distributors, hospitals, prescribing organizations, doctors and the general public.

"SPL allows manufacturers and distributors to create an XML master document that centralizes all the labeling information for a given product and allows it to be accurately and efficiently distributed to the National Drug Code Directory, the DailyMed, the Centers for Medicare and Medicaid Services, and clinical decision support systems at health facilities," said DCL's Howard Shatz, who will lead the seminar. "The result is that data is created once, but used for many purposes with total accuracy," he added.

The new ACA 6004 program requires annual reporting of drug sample distributions to licensed practitioners, hospital pharmacies, and other healthcare entities; electronic records must now identify the types and quantities of drug samples requested and distributed and the name, address, as well as other identifying information.  The Patient Protection and Affordable Care Act's (ACA) Prescription Drug Sample Transparency Program (ACA 6004) was effective April 1st, but the FDA has stated they will not object if companies report by October 1st.

Shatz is an expert on SPL and ACA 6004 requirements for prescription drugs, consumer products, veterinary medicine, homeopathic products and bulk ingredients. An active member of the SPL Working Group, he has been DCL's SPL Project Manager since the FDA's program started in 2005.

About Data Conversion Laboratory, Inc. DCL is a leader in organizing, converting, and moving content to modern formats for wide access and new revenue streams. With expertise across many industries, DCL's proprietary technology matched with US-based project management teams solve clients' complex conversion challenges securely, accurately and on-time. Serving the full range of businesses, government, nonprofits and individuals by future-proofing their content, DCL started in 1981 and is a 100 Top Company in the Digital Content Industry for 2011-2012.

www.dclab.com

Steve Capoccia
617-372-1539
steve@warnerpr.com


'/>"/>
SOURCE Data Conversion Laboratory, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Enrollment of Women in Cardiovascular Trials Fails to Meet Current Federal Mandates
2. CRN Opposes Duplicative Mandates for Supplement Manufacturers
3. New PCMA Ad on Essential Health Benefits: Small Businesses Oppose Costly Mandates Pushed by Drugstore, Drug Company Lobbies
4. PCMA on IOM Essential Health Benefits Report: Employers and Special Interests Will Spar Over Costly Prescription Drug Mandates
5. MicroRNA Biomarkers Provide Reliable Diagnosis from Blood Samples
6. ASPEX Kicks Off Free Send Us Your Sample Microscopy Campaign
7. One-Third of Antimalarial Medicines Sampled in Three African Nations Found to Be Substandard in Large-Scale USP-WHO Study
8. Transgenomic Demonstrates Very High Sensitivity Detection of Tumor-Associated KRAS Mutations in Matched Plasma Samples Using COLD-PCR
9. PLUS Diagnostics Introduces Industrys First System to Eliminate Misidentification of Bone Marrow Samples
10. Amnis Releases AutoSampler Option for the ImageStreamX
11. New England Biolabs Launches NEBNext™ Quick DNA Sample Prep Reagent Sets for Use With Roche/454 Next Generation Sequencing Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2017)... , May 25, 2017  In response to ... , Direct Relief is working with Pfizer to ... available at no cost to community health centers, free ... providers nationwide. "Pfizer has a long-standing ... medicines and ensuring patient safety through educational activities," said ...
(Date:5/22/2017)... 2017  Lilac Corp, the company that sells ... of a new website . The website ... clinical study that showed surprising clearance of the ... individuals suffering from HPV warts, precancerous, or cancerous ... no other treatments that clear the virus. Specifically, ...
(Date:5/18/2017)... May 17, 2017  Bayer announced today that the ... be presented at the 53 rd Annual Meeting ... place June 2-6 in Chicago . ... span prostate, colorectal, liver and thyroid cancers, as well ... Phase II CHRONOS-1 trial of copanlisib in patients with ...
Breaking Medicine Technology:
(Date:5/26/2017)... ... , ... “When the Stars Lead Home”: a poignant story of loss, determination, ... Weigel Douglas, an avid reader who lives in the Pacific Northwest with her husband, ... Hills Adventure Camp. She couldn’t be more grateful. , Twelve-year old Tizzy could not ...
(Date:5/26/2017)... ... May 26, 2017 , ... ... recipient of proceeds from its 14th Annual Clays for Kids fundraiser, to be ... 30, Bennett, Colorado. , As part of BluSky’s partnership with The Adoption ...
(Date:5/26/2017)... ... ... “Cactus Jack: Against All Odds”: the story of Coach Cactus Jack and ... Odds” is the creation of published author, Walter Hubbard, a retired wildlife and fisheries ... child Jane. Walter. Walter and Jane have three adult children and a granddaughter. ...
(Date:5/24/2017)... BELLEVILLE, N.J. (PRWEB) , ... May 24, 2017 ... ... joined Clara Maass Medical Center CEO Mary Ellen, hospital employees, and town officials ... in Belleville. , The facility was developed by Rendina as part of its ...
(Date:5/24/2017)... ... May 24, 2017 , ... Dr. Alan I. Benvenisty, MD ... New York City. He is known for his distinguished expertise and experience in the ... Benvenisty holds sub-specialty training in treating renovascular disease and aortic aneurysm . He ...
Breaking Medicine News(10 mins):